Lauran Neergaard

1 week ago | theitem.com | Lauran Neergaard

By LAURAN NEERGAARD AP Medical WriterWASHINGTON (AP) - The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that could protect millions - although it's unclear how many in the U.S. and abroad will get access to the powerful new option. While a vaccine to prevent HIV still is needed, some experts say the shot - a drug called lenacapavir - could be the next best thing.

1 week ago | oanow.com | Lauran Neergaard

WASHINGTON — The U.S. approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that could protect millions — though it's unclear how many in the U.S. and abroad will get access to the powerful new option. While a vaccine to prevent HIV still is needed, some experts say the shot — a drug called lenacapvir — could be the next best thing.

1 week ago | stuff.co.nz | Lauran Neergaard |Paula Goodyer |Justin Spike |Illia Novikov

Sleeping for too long is worse for your health than a lack of sleep, a new study has suggested. Researchers found people who regularly sleep for fewer than seven hours per night or more than nine hours per night were increasing their risk of death. The study revealed that those sleeping for fewer than seven hours were 14 per cent more likely to die from any cause than those getting the optimal seven to eight hours of shut-eye.

1 week ago | msn.com | Rachel Dobkin |Lauran Neergaard

Microsoft Cares About Your PrivacyMicrosoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will personalise the content and ads that you see. You can select ‘I Accept’ to consent to these uses or click on ‘Manage preferences’ to review your options and exercise your right to object to Legitimate Interest where used.

1 week ago | aol.com | Rachel Dobkin |Lauran Neergaard

The Food and Drug Administration has approved a twice-yearly preventive HIV shot that could protect millions from the virus. People at risk for HIV may choose to take PrEP, a medication that helps prevent HIV infection. PrEp has been prescribed as a daily pill or a shot given every two months. This new twice-yearly drug called lenacapavir is now the longest-lasting type of PrEP.